Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| EOM Pharmaceutical Holdings Inc (PK) | IMUC | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.21 | 07:13:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.21 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0182 - 0.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.21 | USD |
EOM Pharmaceutical Holdings Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 23.79M | 113.27M | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
EOM Pharmaceutical (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMUC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.155 | 0.21 | 0.155 | 0.1786166 | 2,214 | 0.055 | 35.48% |
| 1 Month | 0.20 | 0.21 | 0.1421 | 0.1812141 | 1,077 | 0.01 | 5.00% |
| 3 Months | 0.1801 | 0.30 | 0.0182 | 0.1989752 | 4,247 | 0.0299 | 16.60% |
| 6 Months | 0.30875 | 0.3999 | 0.0182 | 0.2338912 | 3,192 | -0.09875 | -31.98% |
| 1 Year | 0.32279 | 0.40 | 0.0182 | 0.253206 | 3,989 | -0.11279 | -34.94% |
| 3 Years | 0.37 | 0.94 | 0.0182 | 0.4454671 | 6,531 | -0.16 | -43.24% |
| 5 Years | 0.021 | 0.98 | 0.012 | 0.1082139 | 34,515 | 0.189 | 900.00% |
EOM Pharmaceutical (PK) Description
| The Company is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Our development pipeline consists of multiple programs and clinical indications at various stages of development. Our portfolio currently consists of two product candidates: EOM613 and EOM147. |
